Abrocitinib trials for Eczema
All Abrocitinib trials · All Eczema trials
8
Recruiting trials
Phase breakdown
Phase 2 1Phase 3 2Not applicable 5
Recruiting trials studying Abrocitinib for Eczema
- A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
- A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis
- Molecular Signatures in Inflammatory Skin Disease
- Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
- Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Common questions
How many trials study Abrocitinib for Eczema?
8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.